Table 3.
Effects of TCM (mostly flavonoids among core compounds) in COVID-19 evaluated through network pharmacology and molecular docking.
| TCM | Potential effects in COVID-19 | Reference |
|---|---|---|
| TCM prescription Dayuanyin | Suppression of the inflammatory storm and regulation of immune function. | [72] |
| Observed affinity between the core compounds of Dayuanyin (kaempferol, quercetin, 7-Methoxy-2-methyl isoflavone, naringenin, formononetin) and its target genes such as IL-6, IL1β, and CCL2. | ||
| Maxingyigan decoction | Recognized and verified gene targets (including IL-6) and three components of Maxingyigan (quercetin, formononetin, luteolin). | [73] |
| The potential role of Maxingyigan in the prevention and treatment of COVID-19 could be based on its anti-inflammatory and immunity-based actions including the activation of T-cells, lymphocytes, leukocytes, cytokine-cytokine-receptor, and chemokine signaling pathways. | ||
| Toujie Quwen granule | The potential role of Toujie Quwen granule and its key active ingredients (including quercetin, kaempferol, luteolin, and oroxylin A, among others) in the treatment of COVID-19 associated with the mechanisms that elevate immunity, suppress inflammatory stress, and regulate inflammatory responses among others. | [74] |
| Qing-Fei-Pai-Du decoction | Observed immuno-regulatory, anti-inflammatory and multi-organ protective abilities (attributed to four compounds including also flavonoids baicalin and hesperidin and its targets) that could be applicable in COVID-19 management (thrombin and TLR signaling suggested as essential pathways of its anti-inflammatory effects). | [75] |
Abbreviations: CCL2, monocyte chemo-attractant protein-1; IL, interleukin; TCM, Traditional Chinese medicine; TLR, Toll-like receptor.